Literature DB >> 30657968

Inappropriate Antibiotic Prescribing for Acute Bronchiolitis in US Emergency Departments, 2007-2015.

Jesse Papenburg1,2, Patricia S Fontela1,3, Raphael R Freitas4, Brett Burstein4.   

Abstract

One-fourth of patients with bronchiolitis seen in US emergency departments between 2007 and 2015 received antibiotics; 70% of them had no documented bacterial coinfection. Macrolides were prescribed in 38% of the cases. Antibiotic use did not decrease after national recommendations against routine prescribing. Efforts are needed to reduce unnecessary and inappropriate antibiotic use for bronchiolitis.
© The Author(s) 2019. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  antibiotics; bronchiolitis; children

Mesh：

Substances：

Year:  2019        PMID： 30657968     DOI： 10.1093/jpids/piy131

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN： 2048-7193            Impact factor:   3.164


  11 in total

Review 1.  Cognitive bias: how understanding its impact on antibiotic prescribing decisions can help advance antimicrobial stewardship.

Authors:  Bradley J Langford; Nick Daneman; Valerie Leung; Dale J Langford
Journal:  JAC Antimicrob Resist       Date:  2020-12-21

2.  Associations Between Quality Measures and Outcomes for Children Hospitalized With Bronchiolitis.

Authors:  Mersine A Bryan; Amy Tyler; Chuan Zhou; Derek J Williams; David P Johnson; Chén C Kenyon; Heather Haq; Tamara D Simon; Rita Mangione-Smith
Journal:  Hosp Pediatr       Date:  2020-11

3.  Trends Over Time in Use of Nonrecommended Tests and Treatments Since Publication of the American Academy of Pediatrics Bronchiolitis Guideline.

Authors:  Samantha A House; Jennifer R Marin; Matthew Hall; Shawn L Ralston
Journal:  JAMA Netw Open       Date:  2021-02-01

4.  Clinico-virological Profile, Intensive Care Needs, and Outcome of Infants with Acute Viral Bronchiolitis: A Prospective Observational Study.

Authors:  Suresh K Angurana; Lalit Takia; Subhabrata Sarkar; Isheeta Jangra; Ishani Bora; Radha Kanta Ratho; Muralidharan Jayashree
Journal:  Indian J Crit Care Med       Date:  2021-11

5.  Provider views on rapid diagnostic tests and antibiotic prescribing for respiratory tract infections: A mixed methods study.

Authors:  Shana A B Burrowes; Tamar F Barlam; Alexandra Skinner; Rebecca Berger; Pengsheng Ni; Mari-Lynn Drainoni
Journal:  PLoS One       Date:  2021-11-29       Impact factor: 3.240

6.  Unnecessary antibiotic prescribing in pediatric ambulatory care visits for bronchitis and bronchiolitis in the United States, 2006-2015.

Authors:  Rachel L Snyder; Laura M King; Adam L Hersh; Katherine E Fleming-Dutra
Journal:  Infect Control Hosp Epidemiol       Date:  2020-10-16       Impact factor: 3.254

7.  Treatment for acute bronchiolitis before and after implementation of new national guidelines: a retrospective observational study from primary and secondary care in Oslo, Norway.

Authors:  Nicolai Klem; Håvard Ove Skjerven; Beate Nilsen; Mette Brekke; Odd Martin Vallersnes
Journal:  BMJ Paediatr Open       Date:  2021-05-20

8.  Unexpected relationships between frequency of antimicrobial resistance, disease phenotype and emm type in group A Streptococcus.

Authors:  Misu A Sanson; Olga R Macias; Brittany J Shah; Blake Hanson; Luis Alberto Vega; Zain Alamarat; Anthony R Flores
Journal:  Microb Genom       Date:  2019-11

Review 9.  COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works.

Authors:  Andrea Gastaldi; Daniele Donà; Elisa Barbieri; Carlo Giaquinto; Louis J Bont; Eugenio Baraldi
Journal:  Children (Basel)       Date:  2021-12-06

10.  Clinical characteristics of pediatric SARS-CoV-2 infection and coronavirus disease 2019 (COVID-19) in Kuwait.

Authors:  Danah Alsharrah; Fatemah Alhaddad; Munirah Alyaseen; Sarah Aljamaan; Nahar Almutairi; Mariam Ayed; Jesse Papenburg; Mohammad Alghounaim
Journal:  J Med Virol       Date:  2020-12-01       Impact factor: 20.693
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.